Showing results (31-40 of 214) with videos related to
Sort By:
Pageof 22
Expert Opinion on Therapeutic Targets|July 5, 2013
Targeting the ubiquitin-proteasome system for cancer therapyMin Shen, Sara Schmitt, Daniela Buac, et al.Recent Patents on Anti-Cancer Drug Discovery|February 29, 2020
Feasibility of Repurposing Clioquinol for Cancer TherapyRaheel Khan, Harras Khan, Yassen Abdullah, et al.Journal of Cellular Physiology|October 17, 2013
The interplay of AMP-activated protein kinase and androgen receptor in prostate cancer cellsMin Shen, Zhen Zhang, Manohar Ratnam, et al.Current Protein & Peptide Science|January 13, 2017
Discovery of Natural Proteasome Inhibitors as Novel Anticancer Therapeutics: Current Status and PerspectivesHui Wang, Qingzhu Yang, Q Ping Dou, et al.Oncoscience|June 23, 2015
Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compoundsNingning Liu, Hongbiao Huang, Q Ping Dou, et al.Journal of Medicinal Chemistry|September 26, 2008
Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cellsBoris Cvek, Vesna Milacic, Jan Taraba, et al.Frontiers in Molecular Biosciences|April 30, 2021
Targeting Ubiquitin-Proteasome System With Copper Complexes for Cancer TherapyXin Chen, Q Ping Dou, Jinbao Liu, et al.Molecular Pharmacology|September 19, 2002
Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosisAslamuzzaman Kazi, David M Smith, Qing Zhong, et al.Cancer Research|November 3, 2006
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activityDi Chen, Qiuzhi Cindy Cui, Huanjie Yang, et al.Journal of Cellular Biochemistry|November 5, 2016
P-Glycoprotein Inhibition Sensitizes Human Breast Cancer Cells to Proteasome InhibitorsRahul R Deshmukh, Seongho Kim, Yasmine Elghoul, et al.Pageof 22